Celsense

Celsense, Inc. is a biotechnology company based in Pittsburgh, Pennsylvania, specializing in the development of innovative magnetic resonance imaging (MRI) agents designed to non-invasively visualize and quantify biological processes at the cellular level. The company's primary offerings include Cell Sense, a MRI cell tracer for monitoring transplanted cells; Gene Sense, a DNA-encoded marker that allows cells to express their own contrast agent; and V-sense, a fluorine-based MRI tracer. Additionally, Celsense provides Voxel Tracker, which facilitates rapid visualization and quantification of MRI-labeled cells. These products are instrumental in regenerative medicine and immunotherapy, allowing for the monitoring of cellular therapeutics, inflammation, cancer metastases, and immune system responses. Founded in 2005, Celsense collaborates with various pharmaceutical and biotechnology organizations to develop applications suitable for human use.